Here, we review NRG1 fusion-positive cancer and focus on outcomes in PDAC.<h4>Methods</h4>Patients with NRG1 fusion-positive disease at Memorial Sloan Kettering Cancer Center were identified using institutional databases. This evidence concerns the gene NRG1 and cancer.